"small cell networks" trang 12 - tải miễn phí từ tailieunhanh
Randomized phase II study of paclitaxel/ carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapynaïve non-small cell lung cancer in a clinically selected population excluding patients with nonsmoking adenocarcinoma or mutated EGFR

Randomized phase II study of paclitaxel/ carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapynaïve non-small cell lung cancer in a clinically selected population excluding patients with nonsmoking adenocarcinoma or mutated EGFR
7    39    1
Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
7    36    1
Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy

Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy
6    30    1
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
10    36    1
Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: A meta-analysis of published studies involving 32 studies

Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: A meta-analysis of published studies involving 32 studies
13    37    1
Psychogenic fever in a patient with small cell lung cancer: A case report

Psychogenic fever in a patient with small cell lung cancer: A case report
4    39    1
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
9    48    1
The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: Based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume

The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: Based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume
10    43    1
Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Results of a phase II trial (MOVE trial)

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Results of a phase II trial (MOVE trial)
6    27    1
The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer

The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer
6    36    1
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer
8    34    1
Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients

Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients
8    43    1
Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer

Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer
8    38    1
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
8    46    1
Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis
10    35    1
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
7    40    1
Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer

Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer
8    40    1
Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
10    39    1
Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
12    38    1
The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis

The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis
9    73    1